Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Nature Communications ; 12 (2021). - Art.-Nr. 1726 |. - eISSN 2041-1723
- Schlagwort
-
SARS-CoV-2
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2021
- Urheber
-
Wettstein, Lukas
Weil, Tatjana
Conzelmann, Carina
Müller, Janis A.
Groß, Rüdiger
Hirschenberger, Maximilian
Seidel, Alina
Klute, Susanne
Zech, Fabian
Prelli Bozzo, Caterina
Preising, Nico
Fois, Giorgio
Lochbaum, Robin
Knaff, Philip Maximilian
Mailänder, Volker
Ständker, Ludger
Thal, Dietmar
Schumann, Christian
Stenger, Steffen
Kleger, Alexander
Lochnit, Günter
Mayer, Benjamin
Ruiz-Blanco, Yasser B.
Hoffmann, Markus
Sparrer, Konstantin MJ
Pöhlmann, Stefan
Sanchez-Garcia, Elsa
Kirchhoff, Frank
Frick, Manfred
Münch, Jan
- DOI
-
10.18725/OPARU-38069
- URN
-
urn:nbn:de:bsz:289-oparu-38131-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wettstein, Lukas
- Weil, Tatjana
- Conzelmann, Carina
- Müller, Janis A.
- Groß, Rüdiger
- Hirschenberger, Maximilian
- Seidel, Alina
- Klute, Susanne
- Zech, Fabian
- Prelli Bozzo, Caterina
- Preising, Nico
- Fois, Giorgio
- Lochbaum, Robin
- Knaff, Philip Maximilian
- Mailänder, Volker
- Ständker, Ludger
- Thal, Dietmar
- Schumann, Christian
- Stenger, Steffen
- Kleger, Alexander
- Lochnit, Günter
- Mayer, Benjamin
- Ruiz-Blanco, Yasser B.
- Hoffmann, Markus
- Sparrer, Konstantin MJ
- Pöhlmann, Stefan
- Sanchez-Garcia, Elsa
- Kirchhoff, Frank
- Frick, Manfred
- Münch, Jan
- Universität Ulm
Entstanden
- 2021
Ähnliche Objekte (12)
Aprotinin inhibits SARS-CoV-2 replication
Enisamium inhibits SARS-CoV-2 RNA synthesis
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2
Structure-activity relationships of benzamides and isoindolines designed as SARS-CoV protease inhibitors effective against SARS-CoV-2
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
SARS‐CoV‐2 main protease mutation analysis via a kinematic method
European Black Elderberry Fruit Extract Inhibits Replication of SARS-CoV-2 In Vitro
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Alpha-1-Antitrypsin inhibits acute liver failure in mice
Discovery and characterization of protease inhibitors that block SARS-CoV-2 infection
Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
Aprotinin inhibits SARS-CoV-2 replication
Enisamium inhibits SARS-CoV-2 RNA synthesis
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2
Structure-activity relationships of benzamides and isoindolines designed as SARS-CoV protease inhibitors effective against SARS-CoV-2
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
SARS‐CoV‐2 main protease mutation analysis via a kinematic method
European Black Elderberry Fruit Extract Inhibits Replication of SARS-CoV-2 In Vitro
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Alpha-1-Antitrypsin inhibits acute liver failure in mice
Discovery and characterization of protease inhibitors that block SARS-CoV-2 infection
Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
Aprotinin inhibits SARS-CoV-2 replication
Enisamium inhibits SARS-CoV-2 RNA synthesis
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2
Structure-activity relationships of benzamides and isoindolines designed as SARS-CoV protease inhibitors effective against SARS-CoV-2
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
SARS‐CoV‐2 main protease mutation analysis via a kinematic method
European Black Elderberry Fruit Extract Inhibits Replication of SARS-CoV-2 In Vitro
The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue
Alpha-1-Antitrypsin inhibits acute liver failure in mice
Discovery and characterization of protease inhibitors that block SARS-CoV-2 infection